The COLOSSUS Project
Colorectal cancer is the third most common cancer in Europe. COLOSSUS is an EU-funded H2020 project that aims to provide new and more effective ways to classify patients with a specific type of colorectal cancer (microsatellite stable RAS mutant metastatic colorectal cancer or MSS RAS mt mCRC) and to develop better treatments for them. Our ultimate goal is to deliver a personalised medicine approach for patients with MSS RAS mt mCRC that is currently not available.
Project Partners
The COLOSSUS Project brings together a multidisciplinary team of 14 different partners from 8 different countries.
Latest News
Dr Rodrigo Dienstmann, VHIO presents COLOSSUS at the AACR
Dr Rodrigo Dienstmann of Vall d'Hebron University Hospital, Barcelona, Spain presented COLOSSUS at the American Association for Cancer Research (AACR) Intestinal Stem Cells and Colon Cancer: Biology to Therapy conference. The four-day meeting ran from [...]
Darran O’ Connor, RCSI presents COLOSSUS findings at 2018 ASCO
A study: 'SATB2 loss and the immune milieu of colorectal cancer (CRC)' was presented by Dr Darran O' Connor, a cancer biologist at the Royal College of Surgeons Ireland at the Gastrointestinal (Colorectal) Cancer session at the [...]
COLOSSUS exhibits at important PPI event: Patient Voice in Cancer Research
On September 21, 2018, the fifth Patient Voice in Cancer Research event took place at University College Dublin's Conway Institute. At this interactive event, RCSI's Dr Alice O'Farrell presented COLOSSUS at an exhibition alongside several [...]